GB202308846D0 - Fast release oral formulations ii - Google Patents

Fast release oral formulations ii

Info

Publication number
GB202308846D0
GB202308846D0 GBGB2308846.1A GB202308846A GB202308846D0 GB 202308846 D0 GB202308846 D0 GB 202308846D0 GB 202308846 A GB202308846 A GB 202308846A GB 202308846 D0 GB202308846 D0 GB 202308846D0
Authority
GB
United Kingdom
Prior art keywords
oral formulations
release oral
fast release
fast
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2308846.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Algipharma AS
Original Assignee
Algipharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algipharma AS filed Critical Algipharma AS
Priority to GBGB2308846.1A priority Critical patent/GB202308846D0/en
Publication of GB202308846D0 publication Critical patent/GB202308846D0/en
Pending legal-status Critical Current

Links

GBGB2308846.1A 2023-06-13 2023-06-13 Fast release oral formulations ii Pending GB202308846D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2308846.1A GB202308846D0 (en) 2023-06-13 2023-06-13 Fast release oral formulations ii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2308846.1A GB202308846D0 (en) 2023-06-13 2023-06-13 Fast release oral formulations ii

Publications (1)

Publication Number Publication Date
GB202308846D0 true GB202308846D0 (en) 2023-07-26

Family

ID=87291438

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2308846.1A Pending GB202308846D0 (en) 2023-06-13 2023-06-13 Fast release oral formulations ii

Country Status (1)

Country Link
GB (1) GB202308846D0 (en)

Similar Documents

Publication Publication Date Title
EP4097123A4 (en) Coronavirus vaccine formulations
EP4072553A4 (en) Cariprazine release formulations
EP3955910A4 (en) Sustained release formulations
GB202020117D0 (en) Oral cannabinoid formulations
IL306088A (en) Coronavirus vaccine formulations
EP3796915A4 (en) Oral formulations comprising rivaroxaban
IL283593A (en) Oral formulations of branaplam
GB202308846D0 (en) Fast release oral formulations ii
GB202308845D0 (en) Fast release oral formulations i
EP4129413A4 (en) Composition for oral cavity
GB202018889D0 (en) Formulations
GB202009684D0 (en) Formulations
GB2613211B (en) Alkaline oral formulations
GB202208807D0 (en) Alkaline intraoral formulations
GB202315863D0 (en) Formulations
GB202307059D0 (en) Formulations
GB202216961D0 (en) 5-meo-mt formulations
GB202315017D0 (en) Powder for oral solution formulations
GB202204171D0 (en) Novel formulations
GB202114564D0 (en) Oral formulation
GB202311981D0 (en) Oral compositions
GB202306966D0 (en) Oral thin film formulations
FI3932989T3 (en) Bisbenzocyclobutene formulations
GB202115121D0 (en) Formulations
GB202115127D0 (en) Formulations